Publicaciones en las que colabora con ALFONSO CARVAJAL GARCIA PANDO (22)

2016

  1. Carpal tunnel syndrome associated with oral bisphosphonates. A population-based cohort study

    PLoS ONE, Vol. 11, Núm. 1

  2. Genetic variants associated with antithyroid drug-induced agranulocytosis: A genome-wide association study in a European population

    The Lancet Diabetes and Endocrinology, Vol. 4, Núm. 6, pp. 507-516

  3. Impact of regulatory measures on antipsychotics drug consumption in Castilla y León, Spain

    Public Health, Vol. 141, pp. 113-119

2015

  1. Emergency contraceptive pill safety profile. Comparison of the results of a follow-up study to those coming from spontaneous reporting

    Pharmacoepidemiology and Drug Safety, Vol. 24, Núm. 1, pp. 93-97

  2. Guillain-Barré syndrome and influenza vaccines: A meta-analysis

    Vaccine, Vol. 33, Núm. 31, pp. 3773-3778

2014

  1. Hepatotoxicity related to agomelatine and other new antidepressants: A case/noncase approach with information from the portuguese, French, Spanish, and Italian pharmacovigilance systems

    Journal of Clinical Psychopharmacology, Vol. 34, Núm. 3, pp. 327-330

  2. Knowledge upon the emergency contraceptive pill in Spain

    Atencion Farmaceutica, Vol. 16, Núm. 3, pp. 224-228

  3. No differences between men and women in adverse drug reactions related to psychotropic drugs: A survey from France, Italy and Spain

    Fundamental and Clinical Pharmacology, Vol. 28, Núm. 3, pp. 342-348

2013

  1. Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 3, pp. 559-564

2012

  1. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): Changes in the consumption pattern following the introduction of extended release methylphenidate

    Pharmacoepidemiology and Drug Safety, Vol. 21, Núm. 4, pp. 435-441

2011

  1. Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting

    Vaccine, Vol. 29, Núm. 3, pp. 519-522

  2. Hepatitis colestásica por amoxicilina

    Gastroenterologia y Hepatologia, Vol. 34, Núm. 7, pp. 474-477

2010

  1. Estudio sobre cumplimiento terapéutico de antibióticos en oficinas de farmacia

    Atencion Farmaceutica, Vol. 12, Núm. 4, pp. 247-250

  2. Response to rupatadine and heart rhythm disturbances

    Clinical Pharmacology and Therapeutics

2009

  1. Drug Point: Strontium ranelate may cause alopecia

    BMJ (Online)

  2. Heart rhythm disturbances associated with rupatadine: A case series from the Spanish and Portuguese pharmacovigilance systems

    Clinical Pharmacology and Therapeutics, Vol. 85, Núm. 5, pp. 481-484

2007

  1. Gynaecomastia associated with proton pump inhibitors: A case series from the Spanish pharmacovigilance system

    Drug Safety, Vol. 30, Núm. 6, pp. 527-531

2006

  1. HMG CoA reductase inhibitors and impotence: Two case series from the Spanish and French drug monitoring systems

    Drug Safety, Vol. 29, Núm. 2, pp. 143-149

2004

  1. Utilización de Medicamentos para la Osteoporosis en España [2]

    Atencion Primaria

2003

  1. EURO-MED-STAT: Monitoring expenditure and utilization of medicinal products in the European Union countries: A public health approach

    European Journal of Public Health, Vol. 13, Núm. 3, pp. 95-100